Rubin, Mark A.
University of Bern,
Switzerland
2025 Rank: 7291
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pathology
Rank in SubField 1: 316 out of 355674 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 7291 | 7497 |
| Total Cites | 86534 | 98362 |
| H-index | 143 | 150 |
| Hm-index | 34 | 35 |
| Number of Single Authored Papers | 6 | 6 |
| Total Cites to Single Authored Papers | 164 | 171 |
| Number of Single+First Authored Papers | 36 | 36 |
| Total Cites to Single+First Authored Papers | 2886 | 3274 |
| Number of Single+First+Last Authored Papers | 157 | 157 |
| Total Cites to Single+First+Last Authored Papers | 14147 | 16160 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 58356 | 62881 |
| Ratio of Total Citations to Distinct Citing Papers | 1.48 | 1.56 |
| Self-Citation Percentage |
12.02%
|
|
Rubin, Mark A.
University Hospital Bern,
Switzerland
2024 Rank: 7163
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pathology
Rank in SubField 1: 315 out of 334837 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 7163 | 7087 |
| Total Cites | 80514 | 91954 |
| H-index | 139 | 149 |
| Hm-index | 33 | 35 |
| Number of Single Authored Papers | 6 | 6 |
| Total Cites to Single Authored Papers | 157 | 164 |
| Number of Single+First Authored Papers | 36 | 36 |
| Total Cites to Single+First Authored Papers | 2808 | 3195 |
| Number of Single+First+Last Authored Papers | 157 | 157 |
| Total Cites to Single+First+Last Authored Papers | 13499 | 15477 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 54123 | 58489 |
| Ratio of Total Citations to Distinct Citing Papers | 1.49 | 1.57 |
| Self-Citation Percentage |
12.44%
|
|
Rubin, Mark A.
Weill Cornell Medicine,
United States
2023 Rank: 6507
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pathology
Rank in SubField 1: 297 out of 312644 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 6507 | 6592 |
| Total Cites | 73426 | 84073 |
| H-index | 134 | 141 |
| Hm-index | 33 | 34 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 168 | 176 |
| Number of Single+First Authored Papers | 38 | 38 |
| Total Cites to Single+First Authored Papers | 2814 | 3198 |
| Number of Single+First+Last Authored Papers | 158 | 158 |
| Total Cites to Single+First+Last Authored Papers | 12937 | 14876 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 49160 | 53174 |
| Ratio of Total Citations to Distinct Citing Papers | 1.49 | 1.58 |
| Self-Citation Percentage |
12.66%
|
|
Rubin, Mark A.
University of Bern,
Switzerland
2022 Rank: 6365
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pathology
Rank in SubField 1: 292 out of 293195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 6365 | 6230 |
| Total Cites | 69525 | 79965 |
| H-index | 127 | 137 |
| Hm-index | 32 | 34 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 159 | 167 |
| Number of Single+First Authored Papers | 38 | 38 |
| Total Cites to Single+First Authored Papers | 2725 | 3104 |
| Number of Single+First+Last Authored Papers | 158 | 158 |
| Total Cites to Single+First+Last Authored Papers | 12054 | 13911 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 46496 | 50475 |
| Ratio of Total Citations to Distinct Citing Papers | 1.50 | 1.58 |
| Self-Citation Percentage |
13.06%
|
|
Rubin, Mark A.
Weill Cornell Medicine,
United States
2021 Rank: 6193
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pathology
Rank in SubField 1: 287 out of 271773 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 6193 | 6211 |
| Total Cites | 64823 | 74690 |
| H-index | 124 | 131 |
| Hm-index | 32 | 34 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 153 | 161 |
| Number of Single+First Authored Papers | 38 | 38 |
| Total Cites to Single+First Authored Papers | 2676 | 3053 |
| Number of Single+First+Last Authored Papers | 159 | 159 |
| Total Cites to Single+First+Last Authored Papers | 11633 | 13460 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 43388 | 47157 |
| Ratio of Total Citations to Distinct Citing Papers | 1.49 | 1.58 |
| Self-Citation Percentage |
13.21%
|
|
Rubin, Mark A.
Weill Cornell Medicine,
United States
2020 Rank: 6355
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pathology
Rank in SubField 1: 324 out of 230678 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 6355 | 6277 |
| Total Cites | 54691 | 63320 |
| H-index | 113 | 120 |
| Hm-index | 31 | 33 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 146 | 154 |
| Number of Single+First Authored Papers | 39 | 39 |
| Total Cites to Single+First Authored Papers | 2572 | 2949 |
| Number of Single+First+Last Authored Papers | 159 | 159 |
| Total Cites to Single+First+Last Authored Papers | 10636 | 12387 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 36661 | 39925 |
| Ratio of Total Citations to Distinct Citing Papers | 1.49 | 1.59 |
| Self-Citation Percentage |
13.63%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.